In addition, CCR4 has been reported to aggravate tumor malignancy and facilitate tumor metastasis through activation of ERK signaling in bladder cancer, hepatocellular carcinoma and colorectal cancer [20, 23, 24]. Here, CCR4 is linked to urinary bladder carcinoma.